Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705054 · ClinicalTrials.gov registry record
Angina Prevalence and Provider Evaluation of Angina Relief
A clinical trial, sponsored by Saint Luke's Health System.
- Completed
- Registry status
- 1,246
- Enrollment target
NCT01705054: Completed study, sponsored by Saint Luke's Health System.
NCT01705054 is a clinical trial that has completed, run by Saint Luke's Health System. The registered enrollment target is 1,246 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01705054 has completed, sponsored by Saint Luke's Health System.
- COMPLETED
- Registry status
- 1,246 participants
- Enrollment target
Study Summary
The purpose of this study is describe the frequency of chest pain and how chest pain impacts patients' quality of life in the outpatients with chronic coronary artery disease in contemporary cardiology practice settings.
Primary Outcome
Percentage of patients with frequent angina (\>1 episode/week) as measured by the Seattle Angina Questionnaire (SAQ).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,246 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-07-22 |
What the finished NCT01705054 record still lists
NCT01705054 is an observational study that tracks outcomes without assigning an intervention. Its 1,246 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01705054 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01705054 about?
NCT01705054 is a clinical study titled "Angina Prevalence and Provider Evaluation of Angina Relief". The purpose of this study is describe the frequency of chest pain and how chest pain impacts patients' quality of life in the outpatients with chronic coronary artery disease in contemporary cardiology practice settings.
What is the current status of trial NCT01705054?
This trial is currently completed. The enrollment target is 1,246 participants. The study started on 2013-07. Estimated completion is 2015-07-22.
Who is sponsoring clinical trial NCT01705054?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06368245 · 1,244 participants
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia